Literature DB >> 3971764

Remission of invasive thymoma due to chemotherapy. Two patients treated with cyclophosphamide, doxorubicin, and vincristine.

P J Loehrer, P Bonomi, S Goldman, S Reddy, L P Faber, R Jensik, J R Dainauskas.   

Abstract

Information regarding the effectiveness of chemotherapy in cases of invasive thymoma is limited. Two patients in whom the combination of cyclophosphamide, doxorubicin, and vincristine produced remission of invasive thymoma are described. The durations of remission were eight and seven months, respectively. In both patients, recurrence was observed at the site of bulky disease, and a secondary complete response continuing for 37 months was achieved in one of them with radiation therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971764     DOI: 10.1378/chest.87.3.377

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  A case of non-Hodgkin's lymphoma and invasive thymoma treated with R-CHOP therapy.

Authors:  Hiroaki Yamato; Yutaka Tsutsumi; Nobuyuki Ehira; Hiroe Kanamori; Norihiko Shimoyama; Junji Tanaka; Masahiro Imamura; Masahiro Asaka; Tadashi Hasegawa; Nobuo Masauzi
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 2.  Thymomas. Current experience and future directions in therapy.

Authors:  P J Loehrer
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.